Cisplatin Chemotherapy and Cochlear Damage: Otoprotective and Chemosensitization Properties of Polyphenols

被引:18
作者
Fetoni, Anna Rita [1 ,2 ]
Paciello, Fabiola [2 ,3 ]
Troiani, Diana [3 ]
机构
[1] Univ Cattolica Sacro Cuore, Dept Head & Neck Surg, Largo F Vito 1, I-00168 Rome, Italy
[2] Fdn Policlin Univ A Gemelli IRCCS, Rome, Italy
[3] Univ Cattolica Sacro Cuore, Dept Neurosci, Rome, Italy
关键词
cancer; cochlea; therapeutic adjuvant; Nrf-2; chemoresistance; NF-KAPPA-B; INDUCED HEARING-LOSS; AUDITORY HAIR-CELLS; INDUCED OTOTOXICITY; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; GENETIC-VARIANTS; CANCER-PATIENTS; INDUCED NEPHROTOXICITY; SUPEROXIDE-DISMUTASE;
D O I
10.1089/ars.2021.0183
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Significance: Cisplatin is an important component of treatment regimens for different cancers. Notwithstanding that therapeutic success often results from partial efficacy or stabilizing the disease, chemotherapy failure is driven by resistance to drug treatment and occurrence of side effects, such as progressive irreversible ototoxicity. Cisplatin's side effects, including ototoxicity, are often dose limiting.Recent Advances: Cisplatin ototoxicity results from several mechanisms, including redox imbalance caused by reactive oxygen species production and lipid peroxidation, activation of inflammation, and p53 and its downstream pathways that culminate in apoptosis. Considerable efforts in research have targeted development of molecular interventions that can be concurrently administered with cisplatin or other chemotherapies to reduce side effect toxicities while preserving or enhancing the antineoplastic effects. Evidence from studies has indicated some polyphenols, such as curcumin, can help to regulate redox signaling and inflammatory effects. Furthermore, polyphenols can exert opposing effects in different types of tissues, that is, normal cells undergoing stressful conditions versus cancer cells.Critical Issues: This review article summarizes evidence of curcumin antioxidant effect against cisplatin-induced ototoxicity that is converted to a pro-oxidant activity in cisplatin-treated cancer cells, thus providing an ideal chemosensitivity combined with otoprotection. Polyphenols can modulate the adaptive responses to stress in the cisplatin-exposed cochlea. These adaptive effects can result from the interaction/cross talk between the cell's defenses, inflammatory molecules, and the key signaling molecules of signal transducers and activators of transcription 3 (STAT-3), nuclear factor kappa-B (NF-kappa B), p53, and nuclear factor erythroid 2-related factor 2 (Nrf-2).Future Directions: We provide molecular evidence for alternative strategies for chemotherapy with cisplatin addressing the otoprotection and chemosensitization properties of polyphenols.
引用
收藏
页码:1229 / 1245
页数:17
相关论文
共 200 条
  • [81] Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells
    Han, Youngjin
    Kim, Boyun
    Cho, Untack
    Park, In Sil
    Kim, Se Ik
    Dhanasekaran, Danny N.
    Tsang, Benjamin K.
    Song, Yong Sang
    [J]. ONCOGENE, 2019, 38 (45) : 7089 - 7105
  • [82] Cancer Chemoprevention Mechanisms Mediated Through the Keap1-Nrf2 Pathway
    Hayes, John D.
    McMahon, Michael
    Chowdhry, Sudhir
    Dinkova-Kostova, Albena T.
    [J]. ANTIOXIDANTS & REDOX SIGNALING, 2010, 13 (11) : 1713 - 1748
  • [83] Progress in the Development of Preventative Drugs for Cisplatin-Induced Hearing Loss
    Hazlitt, Robert A.
    Min, Jaeki
    Zuo, Jian
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (13) : 5512 - 5524
  • [84] Comprehensive Landscape of Nrf2 and p53 Pathway Activation Dynamics by Oxidative Stress and DNA Damage
    Hiemstra, Steven
    Niemeijer, Marije
    Koedoot, Esmee
    Wink, Steven
    Pip, Janna E.
    Vlasveld, Matthijs
    de Zeeuw, Elisabeth
    van Os, Bram
    White, Andrew
    van de Water, Bob
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 2017, 30 (04) : 923 - 933
  • [85] Drugging the p53 pathway: understanding the route to clinical efficacy
    Hoe, Khoo Kian
    Verma, Chandra S.
    Lane, David P.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (03) : 217 - 236
  • [86] Cancer drug resistance: an evolving paradigm
    Holohan, Caitriona
    Van Schaeybroeck, Sandra
    Longley, Daniel B.
    Johnston, Patrick G.
    [J]. NATURE REVIEWS CANCER, 2013, 13 (10) : 714 - 726
  • [87] Clinical Significance of Keap1 and Nrf2 in Oral Squamous Cell Carcinoma
    Huang, Cong-Fa
    Zhang, Lu
    Ma, Si-Rui
    Zhao, Zhi-Li
    Wang, Wei-Ming
    He, Ke-Fei
    Zhao, Yi-Fang
    Zhang, Wen-Feng
    Liu, Bing
    Sun, Zhi-Jun
    [J]. PLOS ONE, 2013, 8 (12):
  • [88] Oxidative stress-induced apoptosis of cochlear sensory cells: otoprotective strategies
    Huang, T
    Cheng, AG
    Stupak, H
    Liu, W
    Kim, A
    Staecker, H
    Lefebvre, PP
    Malgrange, B
    Kopke, R
    Moonen, G
    Van de Water, TR
    [J]. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2000, 18 (2-3) : 259 - 270
  • [89] Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals
    Ishida, S
    Lee, J
    Thiele, DJ
    Herskowitz, I
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (22) : 14298 - 14302
  • [90] The emerging role of the Nrf2-Keap1 signaling pathway in cancer
    Jaramillo, Melba C.
    Zhang, Donna D.
    [J]. GENES & DEVELOPMENT, 2013, 27 (20) : 2179 - 2191